TD
Therapeutic Areas
Pelthos Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZELSUVMI™ (berdazimer topical gel, 10.3%) | Molluscum Contagiosum | Approved |
| Xepi® (ozenoxacin) Cream, 1% | Impetigo | Approved |
| Xeglyze® (abametapir) Lotion, 0.74% | Head Lice | Approved |
| Drug | Indication | Phase |
|---|---|---|
| ZELSUVMI™ (berdazimer topical gel, 10.3%) | Molluscum Contagiosum | Approved |
| Xepi® (ozenoxacin) Cream, 1% | Impetigo | Approved |
| Xeglyze® (abametapir) Lotion, 0.74% | Head Lice | Approved |